Kshitij Wagh

4.4k total citations · 2 hit papers
28 papers, 1.1k citations indexed

About

Kshitij Wagh is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Kshitij Wagh has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 16 papers in Virology and 9 papers in Molecular Biology. Recurrent topics in Kshitij Wagh's work include HIV Research and Treatment (16 papers), HIV/AIDS drug development and treatment (10 papers) and vaccines and immunoinformatics approaches (6 papers). Kshitij Wagh is often cited by papers focused on HIV Research and Treatment (16 papers), HIV/AIDS drug development and treatment (10 papers) and vaccines and immunoinformatics approaches (6 papers). Kshitij Wagh collaborates with scholars based in United States, United Kingdom and India. Kshitij Wagh's co-authors include Bette Korber, Dan H. Barouch, Beatrice H. Hahn, Barton F. Haynes, David C. Montefiori, James Theiler, Will Fischer, Kathryn E. Stephenson, S. Gnanakaran and George M. Shaw and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature reviews. Immunology.

In The Last Decade

Kshitij Wagh

26 papers receiving 1.0k citations

Hit Papers

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing... 2021 2026 2022 2024 2021 2022 50 100 150 200

Peers

Kshitij Wagh
Jinal N. Bhiman South Africa
Tandile Hermanus South Africa
Kristen W. Cohen United States
Raiees Andrabi United States
Li‐Hua Ping United States
Harry B. Gristick United States
Brent Welcher United States
Kshitij Wagh
Citations per year, relative to Kshitij Wagh Kshitij Wagh (= 1×) peers Henning Gruell

Countries citing papers authored by Kshitij Wagh

Since Specialization
Citations

This map shows the geographic impact of Kshitij Wagh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kshitij Wagh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kshitij Wagh more than expected).

Fields of papers citing papers by Kshitij Wagh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kshitij Wagh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kshitij Wagh. The network helps show where Kshitij Wagh may publish in the future.

Co-authorship network of co-authors of Kshitij Wagh

This figure shows the co-authorship network connecting the top 25 collaborators of Kshitij Wagh. A scholar is included among the top collaborators of Kshitij Wagh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kshitij Wagh. Kshitij Wagh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Misra, Milind, et al.. (2024). HIResist: a database of HIV-1 resistance to broadly neutralizing antibodies. Bioinformatics. 40(3). 5 indexed citations
3.
Giorgi, Elena, Hui Li, Bhavna Hora, et al.. (2024). Viral Envelope Evolution in Simian–HIV-Infected Neonate and Adult-Dam Pairs of Rhesus Macaques. Viruses. 16(7). 1014–1014. 1 indexed citations
4.
Henderson, Rory, Ye Zhou, Victoria Stalls, et al.. (2023). Structural basis for breadth development in the HIV-1 V3-glycan targeting DH270 antibody clonal lineage. Nature Communications. 14(1). 2782–2782. 7 indexed citations
5.
Lasrado, Ninaad, Ai‐ris Y. Collier, Nicole P. Hachmann, et al.. (2023). Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86. Vaccine. 41(47). 6904–6909. 53 indexed citations
6.
Beesley, Lauren J., Kelly R. Moran, Kshitij Wagh, et al.. (2023). SARS-CoV-2 variant transition dynamics are associated with vaccination rates, number of co-circulating variants, and convalescent immunity. EBioMedicine. 91. 104534–104534. 16 indexed citations
7.
Haynes, Barton F., Kevin Wiehe, Persephone Borrow, et al.. (2022). Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies. Nature reviews. Immunology. 23(3). 142–158. 162 indexed citations breakdown →
8.
Dagotto, Gabriel, John D. Ventura, David R. Martinez, et al.. (2022). Immunogenicity and protective efficacy of a rhesus adenoviral vaccine targeting conserved COVID-19 replication transcription complex. npj Vaccines. 7(1). 125–125. 4 indexed citations
9.
Crooks, Emma T., E. Duggan, Jinsong Zhang, et al.. (2021). Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens. PLoS Pathogens. 17(10). e1009807–e1009807. 8 indexed citations
10.
Shen, Xiaoying, Haili Tang, Charlene McDanal, et al.. (2021). SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines. Cell Host & Microbe. 29(4). 529–539.e3. 222 indexed citations breakdown →
11.
Wagh, Kshitij, et al.. (2021). Combinations of Single Chain Variable Fragments From HIV Broadly Neutralizing Antibodies Demonstrate High Potency and Breadth. Frontiers in Immunology. 12. 734110–734110. 5 indexed citations
12.
Shen, Xiaoying, Haili Tang, Charlene McDanal, et al.. (2021). SARS-CoV-2 Variant B.1.1.7 is Susceptible to Neutralizing Antibodies Elicited by Ancestral Spike Vaccines. SSRN Electronic Journal.
13.
Wagh, Kshitij, Beatrice H. Hahn, & Bette Korber. (2020). Hitting the sweet spot: exploiting HIV-1 glycan shield for induction of broadly neutralizing antibodies. Current Opinion in HIV and AIDS. 15(5). 267–274. 18 indexed citations
14.
Wagh, Kshitij, Michael S. Seaman, Dan H. Barouch, et al.. (2018). Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections. PLoS Pathogens. 14(3). e1006860–e1006860. 57 indexed citations
15.
Jülg, Boris, Po-Ting Liu, Kshitij Wagh, et al.. (2017). Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail. Science Translational Medicine. 9(408). 96 indexed citations
16.
Korber, Bette, Peter Hraber, Kshitij Wagh, & Beatrice H. Hahn. (2017). Polyvalent vaccine approaches to combat HIV‐1 diversity. Immunological Reviews. 275(1). 230–244. 36 indexed citations
17.
Veillette, Maxime, Jérémie Prévost, Eric Sanders‐Buell, et al.. (2016). Histidine 375 Modulates CD4 Binding in HIV-1 CRF01_AE Envelope Glycoproteins. Journal of Virology. 91(4). 17 indexed citations
18.
Wagh, Kshitij, et al.. (2014). Bird to Human Transmission Biases and Vaccine Escape Mutants in H5N1 Infections. PLoS ONE. 9(7). e100754–e100754. 2 indexed citations
19.
Abbink, Peter, Lori F. Maxfield, David Ng’ang’a, et al.. (2014). Construction and Evaluation of Novel Rhesus Monkey Adenovirus Vaccine Vectors. Journal of Virology. 89(3). 1512–1522. 38 indexed citations
20.
Wagh, Kshitij, Gabriela Alexe, Anupama Reddy, et al.. (2012). Lactase Persistence and Lipid Pathway Selection in the Maasai. PLoS ONE. 7(9). e44751–e44751. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026